Funder
China Scholarship Council
National Natural Science Foundation of China
Shanghai Pujiang Program
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference34 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
2. Pu N, Lv Y, Zhao G, Lee W, Nuerxiati A, Wang D, Xu X, Kuang T, Wu W, Lou W. Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimate. Future Oncol. 2018;14:165–75.
3. McBride A, Bonafede M, Cai Q, Princic N, Tran O, Pelletier C, Parisi M, Patel M. Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX. Expert Rev Clin Pharmacol. 2017;10:1–8.
4. Yang JQ, Wei T, Chen YW, Bai XL, Liang TB. Advances in immunotherapy of pancreatic ductal adenocarcinoma. Zhonghua Wai Ke Za Zhi. 2017;55:396–400.
5. Li X, Xu JX. A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy. J Theor Biol. 2016;406:42–51.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献